{"slideshow_credits": null, "snippet": "The Irish pharmaceutical company Shire will acquire the outstanding shares of ViroPharma of Pennsylvania for $50 a share in a move intended to bolster its roster of treatments for rare diseases.", "abstract": "The Irish pharmaceutical company Shire will acquire the outstanding shares of ViroPharma of Pennsylvania for $50 a share in a move intended to bolster its roster of treatments for rare diseases.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://dealbook.nytimes.com/2013/11/11/shire-drug-maker-to-pay-4-2-billion-for-u-s-biopharmaceutical-firm/", "lead_paragraph": null, "headline": {"main": "Shire of Ireland to Pay $4.2 Billion for U.S. Drug Maker", "print_headline": "Bolstering Its Base", "kicker": "DealBook"}, "_id": "5280a05038f0d87ac8c7b486", "word_count": "323", "multimedia": [], "pub_date": "2013-11-11T04:11:18Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "persons", "value": "Milano, Vincent J", "rank": "1"}, {"name": "persons", "value": "Ornskov, Flemming", "rank": "2"}, {"name": "organizations", "value": "Shire PLC", "rank": "1"}, {"name": "organizations", "value": "ViroPharma Inc", "rank": "2"}, {"name": "subject", "value": "Adderall (Drug)", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "3"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}